Q1FY21 results: Eveready Industries India net profit rises by 261.51 per cent YoY to Rs 24.98 crore Q1FY21 results: Eveready Industries India net profit rises by 261.51 per cent YoY to Rs 24.98 crore DSIJ Intelligence / Wednesday, September 9, 2020 / Article rating: 3.2 The consolidated net profit in Q1FY21 came in at Rs 24.98 crore, which rose by 261.51 per cent, as compared to Q1FY20, when it reported a profit of Rs 6.91 crore.
The P/E Ratio The P/E Ratio Price-Earnings Ratio DSIJ Intelligence / Wednesday, September 9, 2020 / Article rating: 4.5 The price-to-earnings ratio is the relationship between the current share price and earnings per share (EPS). It is the ratio between the current share price and EPS. This ratio is also known as price multiple or earnings multiple. Usually, for this, the earnings of a company of the last 12 months or one year are used.
Understanding Liquidity Ratios Understanding Liquidity Ratios DSIJ Intelligence / Wednesday, September 9, 2020 / Article rating: 4.7 Financial ratios are mathematical relationships between two entities, accounts or categories. These relationships between the various accounts in the financial statements help all concerned stakeholders to understand the performance of a company and also helps understand those areas that need improvement.
Sensex, Nifty close in red; Alembic zooms by nearly 9 per cent, SBI declines by more than 4 per cent Sensex, Nifty close in red; Alembic zooms by nearly 9 per cent, SBI declines by more than 4 per cent DSIJ Intelligence / Wednesday, September 9, 2020 / Article rating: 3.9 On Wednesday, Sensex closed at 38,193.92, declining by 171.43 points or 0.45 per cent while Nifty fell by 39.35 points or 0.35 per cent to settle at 11,278. In today’s session, banks, financial, and realty stocks witnessed a major sell-off.
Zydus Cadila gets USFDA nod for Empagliflozin & Linagliptin tablets Zydus Cadila gets USFDA nod for Empagliflozin & Linagliptin tablets DSIJ Intelligence / Wednesday, September 9, 2020 / Article rating: 4.5 Zydus Cadila informed the exchanges on Wednesday that it has received tentative approval from United States Food & Drug Administration (USFDA) to market Empagliflozin and Linagliptin tablets (US RLD: Glyxambi tablets) in the strengths of 10 mg/5 mg and 25 mg/5 mg.
Gold prices decline by almost 8 per cent in a month Gold prices decline by almost 8 per cent in a month DSIJ Intelligence / Wednesday, September 9, 2020 / Article rating: 4.7 During Wednesday’s trading session, gold prices slipped again as profit booking was seen across equities. Sensex was in negative territory, down by more than 300 points.
Things to remember before switching from mutual funds to stocks Things to remember before switching from mutual funds to stocks DSIJ Intelligence / Wednesday, September 9, 2020 / Article rating: 4.3 Lately, we have seen people moving from mutual funds to investing in direct stocks. Here are a few things that one should remember while making such a switch.
Reliance gains post announcing investment of Rs 7,500 crore by Silver Lake Reliance gains post announcing investment of Rs 7,500 crore by Silver Lake DSIJ Intelligence / Wednesday, September 9, 2020 / Article rating: 4.6 This is for the second time that Silver Lake has shown interest in investing in the subsidiary of Reliance Industries after the $1.35 billion investment in Jio Platforms, earlier this year.
India auto unit sales likely to decline by at least 30 per cent in 2020 India auto unit sales likely to decline by at least 30 per cent in 2020 Nidhi Jani / Wednesday, September 9, 2020 / Article rating: 5.0 On the other side, the global automotive industry's outlook has been changed to stable from negative. It said that the stable outlook for the global automotive industry reveals growing sales through 2021, with continued but slow increase through 2023.
Q1FY21 results: Dishman Carbogen Amics records net loss of Rs 21.43 crore Q1FY21 results: Dishman Carbogen Amics records net loss of Rs 21.43 crore DSIJ Intelligence / Wednesday, September 9, 2020 / Article rating: 5.0 The consolidated net sales reported in Q1FY21 came in at Rs 474.41 crore, which declined by 9.1 per cent YoY from Rs 521.9 crore in Q1FY20.